treatment regimens
patients
endometrial disease
climacteric women
oestrogen therapy
Cystic hyperplasia
associated with
unopposed oestrogen therapy
progestagen
courses
days
norethisterone
reversion
cases
cystic hyperplasia
cases
atypical
hyperplasia
cases
endometrial carcinoma
problems
inappropriate
unopposed oestrogen therapy
severe
hyperplasia
malignancy
Cyclical
oestrogen therapy
7
days
progestagen
increase
risk
endometrial hyperplasia
carcinoma
